Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

13Therapeutics

13Therapeutics
2008 FOUNDED
PRIVATE STATUS
Grant LATEST DEAL TYPE
$244K LATEST DEAL AMOUNT
3 INVESTORS
Description

Provider of drug development and research services. The company provides drug development and research services for identifying, characterizing, and optimizing anti-inflammatory peptide therapeutics.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 4640 South West Macadam Avenue
  • Suite 200D
  • Portland, OR 97239
  • United States

+1 (503) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore 13Therapeutics’s full profile, request a free trial.

13Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 08-Jan-2016 $244K Completed Startup
2. Grant 21-Jan-2011 00.00 Completed Startup
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

13Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Qualifying Therapeutic Discovery Project Government 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
OTRADI Bioscience Incubator Accelerator/Incubator 000 0000 000000 0

13Therapeutics Executive Team (2)

Name Title Board
Seat
Contact
Info
Steven Hefeneider Ph.D Founder, Board Member, President and Chief Executive Officer
Sharon McCoy Board Member, Vice-President of Product Development & Director of Research

13Therapeutics Board Members (5)

Name Representing Role Since Contact
Info
Denis Burger Ph.D Self Board Member 000 0000
Sharon McCoy 13Therapeutics Board Member, Vice-President of Product Development & Director of Research 000 0000
Steven Gillis Ph.D Self Board Member 000 0000
Steven Hefeneider Ph.D 13Therapeutics Founder, Board Member, President and Chief Executive Officer 000 0000
Thomas Bruggere Self Board Member 000 0000